Research Topics
| G M CliffordSummaryAffiliation: International Agency for Research on Cancer Country: France Publications
| Collaborators
|
Detail Information
Publications
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infectionG M Clifford
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Br J Cancer 106:447-52. 2012..Immunodeficiency and AIDS-related pulmonary infections have been suggested as independent causes of lung cancer among HIV-infected persons, in addition to smoking...
Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderlineMark Schiffman
Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, 20892, USA
Infect Agent Cancer 4:8. 2009..This article describes for open discussion an approach recently taken by a World Health Organization International Agency for Research on Cancer (IARC) Monographs Working Group to re-assess the carcinogenicity of different HPV types...
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinomaGary M Clifford
International Agency for Research on Cancer, Lyon, France
AIDS 22:2135-41. 2008..To investigate HIV-related immunodeficiency as a risk factor for hepatocellular carcinoma (HCC) among persons infected with HIV, while controlling for the effect of frequent coinfection with hepatitis C and B viruses...
Hodgkin lymphoma in the Swiss HIV Cohort StudyGary M Clifford
International Agency for Research on Cancer, Lyon, France
Blood 113:5737-42. 2009..In conclusion, HL risk does not appear to be increasing in recent years or among PHIV using cART in Switzerland, and there was no evidence that HL risk should be increased in the setting of improved immunity...
Immunity, infection, and cancerGary Clifford
International Agency for Research on Cancer, 69372 Lyon Cedex 08, France
Lancet 370:6-7. 2007
Cancer risk in HIV-infected persons: influence of CD4(+) countGary M Clifford
International Agency for Research on Cancer, Lyon Cedex 08, France
Future Oncol 5:669-78. 2009....
Human papillomavirus types among women infected with HIV: a meta-analysisGary M Clifford
International Agency for Research on Cancer, Lyon, France
AIDS 20:2337-44. 2006..It is not known to what extent these different types are associated with high-grade squamous intraepithelial lesions (HSIL) and cancer...
Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseasesGary Clifford
International Agency for Research on Cancer, 150 cours Albert Thomas, Lyon Cedex 08, France
Vaccine 24:S3/26-34. 2006..After HPV-16/18, the six most common HPV types are the same in all world regions, namely 31, 33, 35, 45, 52 and 58; these account for an additional 20% of cervical cancers worldwide...
Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysisG M Clifford
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Lancet 366:991-8. 2005..We aimed to compare HPV-type distribution in representative samples of women from different world regions...
Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancerGary M Clifford
IARC, 150 cours Albert Thomas, F 69372 Lyon Cedex 08, France
Cancer Epidemiol Biomarkers Prev 14:1157-64. 2005..Some regional differences in the relative importance of HPV genotypes in LSIL were noted...
Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysisG M Clifford
Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150, cours Albert Thomas, 69008, Lyon, France
Br J Cancer 89:101-5. 2003..These data suggest that HSILs infected with HPV16, 18 and 45 preferentially progress to SCC. This may have implications for follow-up protocols of future HPV-based cervical cancer screening programmes and for HPV vaccine trials...
Human papillomavirus infection in women with and without cervical cancer in Ibadan, NigeriaClement Okolo
International Agency for Research on Cancer, Lyon, France
Infect Agent Cancer 5:24. 2010..Concerns have been raised that the proportion of cervical cancer preventable by human papillomavirus (HPV) 16/18 vaccines might be lower in sub-Saharan Africa than elsewhere...
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysisG M Clifford
International Agency for Research on Cancer, 150, cours Albert Thomas, 69008 Lyon, France
Br J Cancer 88:63-73. 2003..A majority of ICC was associated with HPV16 or 18 in all regions, but approximately a quarter of all ICC cases were associated with one of 16 other HPV types, their distribution varying by region...
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapyGary M Clifford
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
J Natl Cancer Inst 97:425-32. 2005....
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort StudyS Franceschi
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Br J Cancer 103:416-22. 2010..It also led to marked increases in their life expectancy...
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapyS Franceschi
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Br J Cancer 99:800-4. 2008..06; 95% CI, 0.02-0.17). Thirty-three out of 52 (63.5%) KS cases among HAART users arose among PWHA who had stopped treatment or used HAART for less than 6 months...
Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence SurveysSalvatore Vaccarella
International Agency for Research on Cancer, Lyon, France
Int J Epidemiol 37:536-46. 2008..Smoking increases the risk of squamous-cell carcinoma of the cervix, but it is not clear whether smoking increases the risk of acquisition or persistence of human papillomavirus (HPV) infection...
Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort StudyS Franceschi
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Br J Cancer 95:1598-602. 2006..37; 95% CI: 1.03-5.43). No relationships between NHL risk and anti-HBc or HBsAg emerged. Coinfection with HIV and HCV or HBV did not increase NHL risk compared to HIV alone in the SHCS...
Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South KoreaGary M Clifford
IARC, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Cancer Epidemiol Biomarkers Prev 16:1874-9. 2007..In contrast, HPV seropositivity among men was not associated with sexual behavior or the presence of HPV DNA. Seroprevalence correlates with genital HPV exposure in young women, but its meaning in young men is unclear...
Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based studyM Dai
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Br J Cancer 95:96-101. 2006..No significant difference in HPV positivity was observed by educational level, sexual habits, reproductive history or use of contraceptive methods in this rural low-income Chinese population...
Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence SurveysSalvatore Vaccarella
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Cancer Epidemiol Biomarkers Prev 19:2379-88. 2010..Few human papillomavirus (HPV) seroprevalence studies have been carried out in women from low-resource countries...
HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomasAimee R Kreimer
International Agency for Research on Cancer, Lyon, France
Int J Cancer 115:329-32. 2005....
Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveysSalvatore Vaccarella
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Cancer Epidemiol Biomarkers Prev 15:326-33. 2006..Our study showed an effect of both women's and their husbands' sexual behavior on HPV positivity. Furthermore, it suggests some differences in the pattern of the association between sexual behavior and different HPV types...
Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter studyMin Dai
IARC, Lyon, France
Cancer Res 64:468-71. 2004..0; 95% confidence interval, 0.2-5.4). TP53 inactivation is a major mechanism of HPV-related carcinogenesis in the oral cavity and oropharynx. The role of HPV in cancers also containing TP53 mutations remains to be clarified...
Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic reviewAimee R Kreimer
International Agency for Research on Cancer, Lyon, France
Cancer Epidemiol Biomarkers Prev 14:467-75. 2005..Small sample size and publication bias complicate the assessment of the prevalence of HPV in head and neck sites beyond the oropharynx...
Variations in the age-specific curves of human papillomavirus prevalence in women worldwideSilvia Franceschi
International Agency for Research on Cancer, Lyon, France
Int J Cancer 119:2677-84. 2006..These differences, however, underline that great caution should be used in inferring the natural history of HPV from age-specific prevalences...
Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysisHugo De Vuyst
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Int J Cancer 124:1626-36. 2009..This proportion would be similar for the corresponding high-grade lesions of the vagina and anus, but higher for VIN2/3 (75%) than for vulvar carcinoma...
HPV16 genetic variation and the development of cervical cancer worldwideI Cornet
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Br J Cancer 108:240-4. 2013..Factors that favour a small proportion of HPV16 infections to progress to cancer are still poorly understood, but several studies have implicated a role of HPV16 genetic variation...
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapyJerry Polesel
Epidemiology and Biostatics Unit, Aviano Cancer Center, Aviano, Italy
AIDS 22:301-6. 2008..To assess the long-term effect of HAART on non-Hodgkin lymphoma (NHL) incidence in people with HIV (PHIV)...
Fraction of cervical neoplasias due to human papillomavirus 16 and 18 in vaccine trialsSilvia Franceschi
Int J Cancer 122:719-20. 2008
Human papillomavirus infection among 100 oesophageal cancer cases in the People's Republic of ChinaMin Dai
Int J Cancer 121:1396-8. 2007
Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisationRui fang Wu
Department of Obstetrics and Gynecology, Shenzhen Hospital of Beijing University, Shenzhen, China
Int J Cancer 121:1306-11. 2007....
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis updateJennifer S Smith
Department of Epidemiology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599 7435, USA
Int J Cancer 121:621-32. 2007..Data on HPV-typed ICC and HSIL cases were particularly scarce from large regions of Africa and Central Asia...
Re: A study of the impact of adding HPV types to cervical cancer screening and triage testsSilvia Franceschi
J Natl Cancer Inst 97:938-9; author reply 939-41. 2005
Drug or symptom-induced depression in men treated with alpha 1-blockers for benign prostatic hyperplasia? A nested case-control studyGary M Clifford
Department of Pharmacoepidemiology and Public Health, Postgraduate Medical School, University of Surrey, Guildford, UK
Pharmacoepidemiol Drug Saf 11:55-61. 2002..The aim was to assess the risk of depression with alpha 1-blockers independently of that associated with symptoms being treated and concurrent illness...
Incidence, prevalence and management of lower urinary tract symptoms in men in the UKJohn Logie
Department of Pharmacoepidemiology and Public Health, Postgraduate Medical School, University of Surrey, Guildford, UK
BJU Int 95:557-62. 2005..The accompanying postponement of surgery/catheterization is likely to be a result, at least in part, of successful earlier medical treatment and the treatment of a greater proportion of symptomatic men...
No risk of drug-associated liver injury with alpha1-adrenoreceptor blocking agents in men with BPH: results from an observational study using the GPRDGary M Clifford
Department of Pharmacoepidemiology, Postgraduate Medical School, University of Surrey, Guildford, UK
Pharmacoepidemiol Drug Saf 14:75-80. 2005..CONCLUSIONS: This study could not offer any evidence to support an association between exposure to alpha1-blockers and liver injury in men with LUTS/BPH...
